Vetix Inc.: Naphazoline HCI and Pheniramine Maleate Eye Drops Recalled for Poisoning Risk

Agency Publication Date: October 6, 2014

Summary

Vetix Inc. is recalling approximately 6,429 bottles of veterinary eye drops, including Naphazoline HCI (0.025%) and Pheniramine Maleate (0.3%), because they contain active ingredients that can be dangerous if accidentally swallowed. These products are sold in 15-mL oval eye drop containers inside brand name boxes and were distributed across 17 states and Puerto Rico. While these are veterinary products, the packaging lacks the child-resistant safety features required to prevent accidental ingestion by children, which can lead to serious health complications.

Risk

The products contain active ingredients that can cause serious harm or life-threatening reactions in children if accidentally ingested, as the packaging does not include necessary safety safeguards to prevent access by minors.

What You Should Do

Locate your eye drop bottles and check the labels and boxes for the following identifying information: Naphazoline HCI 0.025% with Lot # 083012 (Exp. Date 8/14) or Pheniramine Maleate 0.3% with Lot # 112612 (Exp. Date 11/15).
Immediately store these products in a secure location that is completely out of the reach and sight of children.
Contact your veterinarian or healthcare provider if you have any concerns about the use of these products or if an accidental ingestion has occurred.
Return any unused product to the place of purchase for a refund and contact Vetix Inc. for further instructions regarding the disposal or return of the affected medication.
For additional questions or to report a problem, contact the FDA's Center for Veterinary Medicine at 240-402-7002.

Your Remedy Options

Full Refund

Healthcare consultation and pharmacy refund

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund.

Affected Products

Product: Naphazoline HCI - 0.025% (14.78 mL)

Model:

V-003-2015

Lot Numbers:

083012 (Exp. Date 8/14)

Date Ranges: Expiration Date: August 2014

Product: Pheniramine Maleate 0.3% (14.78 mL)

Model:

V-004-2015

Lot Numbers:

112612 (Exp. Date 11/15)

Date Ranges: Expiration Date: November 2015

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 69161

Status: Resolved

Manufacturer: Vetix Inc.

Manufactured In: United States

Units Affected: 2 products (3,093; 3,336)

Distributed To: Florida, Colorado, Pennsylvania, Ohio, Texas, California, Michigan, Kentucky, North Carolina, Massachusetts, Minnesota, Idaho, Oklahoma, New York, Louisiana, South Carolina, Puerto Rico

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

Summary

What You Should Do

Locate your eye drop bottles and check the labels and boxes for the following identifying information: Naphazoline HCI 0.025% with Lot # 083012 (Exp. Date 8/14) or Pheniramine Maleate 0.3% with Lot # 112612 (Exp. Date 11/15).

Immediately store these products in a secure location that is completely out of the reach and sight of children.

Contact your veterinarian or healthcare provider if you have any concerns about the use of these products or if an accidental ingestion has occurred.

Return any unused product to the place of purchase for a refund and contact Vetix Inc. for further instructions regarding the disposal or return of the affected medication.

For additional questions or to report a problem, contact the FDA's Center for Veterinary Medicine at 240-402-7002.